LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management - Scorecard - MDSpire

LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management

  • By

  • Haixiao Liu

  • Yue Hu

  • Dongtao Li

  • Boyuan Shi

  • Yupeng Niu

  • Xinche Zhang

  • Guangda Zheng

  • Changlin Li

  • Lingyun Wang

  • Yanju Bao

  • January 19, 2026

  • 0 min

Share

Clinical Scorecard: Collaborative Model Utilizing Large Language Technology for Improved Assessment and Management of Cancer Pain

At a Glance

CategoryDetail
ConditionCancer pain with multifactorial mechanisms and variable opioid response
Key MechanismsMulti-agent LLM framework simulating clinical expert reasoning for pain assessment and management
Target PopulationPatients with cancer experiencing pain
Care SettingOncology clinical settings utilizing electronic medical records

Key Highlights

  • OncoPainBot integrates four specialized LLM agents: Pain-Extraction, Pain-Mechanism Reasoning, Treatment-Planning, and Safety-Check.
  • Claude-4 combined with Retrieval-Augmented Generation (RAG) achieved optimal performance in semantic consistency and evidence-based reasoning.
  • Clinical validation showed high decision-making accuracy (0.841) in analgesic recommendations with reliable drug selection.

Guideline-Based Recommendations

Diagnosis

  • Conduct comprehensive cancer pain assessment using multi-dimensional clinical data.
  • Utilize evidence-based reasoning to identify pain mechanisms influencing opioid response.

Management

  • Apply personalized analgesic care plans integrating opioid and non-opioid treatments based on pain mechanism reasoning.
  • Follow transparent, clinical-based frameworks for treatment planning and safety checks.

Monitoring & Follow-up

  • Regularly monitor patient-specific factors influencing pain and treatment response.
  • Adjust management plans based on ongoing assessment and safety evaluations.

Risks

  • Be aware of high-risk adverse reactions associated with opioid use in cancer pain.
  • Ensure safety-check mechanisms are in place to minimize medication errors and adverse events.

Patient & Prescribing Data

Cancer patients with documented pain in electronic medical records

High concordance between AI-generated analgesic recommendations and clinical decisions, with errors mainly due to patient-specific factors rather than drug selection.

Clinical Best Practices

  • Integrate AI-driven multi-agent frameworks to support expert-level cancer pain assessment and management.
  • Employ retrieval-augmented generation techniques to enhance evidence-based clinical decision-making.
  • Maintain transparency and explainability in AI recommendations to foster clinical trust and adoption.

References

Original Source(s)

Related Content